MD, Deputy Director, Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, Milan
After decades of waiting POP-RT and RTOG 0534 SPPORT trial have demonstrated the added value of ENRT for HR Prostate cancer, and for biochemical relapses, respectively. There are no clear indications for lymph node metastases. Can we perform a very targeted treatment based on PSMA PET/CT?
How Can Doctors in Good Conscience Continue Recommending 42 Radiation Sessions for Prostate Cancer When 5 Are as Safe and Effective? The latest research published in the New England Journal of Medicine proves that 5 SBRT Radiation Therapy Sessions With CyberKnife Are As Effective and Safe as Other Types of Radiation Requiring 32 or 42 Treatment Sessions for Low-to-Intermediate-Risk Localized Prostate Cancer Five-fraction SBRT was non-inferior to control radiotherapy with respect to biochemical or clinical failure and may be an efficacious treatment option for patients with low-to-intermediate-risk localized prostate cancer. Go to CyberKnife Miami's blog now to see the research proving it. CyberKnife Center of Miami "The Beam of Life" #cancertreatmentmiami #cancertreatmentmiamifl #cyberknifeforprostatecancer #cyberknifetreatmentforprostatecancer https://lnkd.in/gaxJysTU
An MRI-based imaging technique developed by our emeritus Professor Kevin Brindle and colleagues at the Cancer Research UK Cambridge Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working. Read more: https://lnkd.in/enBe7Rsa
A study on the use of MRI and biopsy for initial assessment of aggressive bladder cancer found it increased speed of treatment by up to six weeks. Find out more about the study, published in the Journal of Clinical Oncology, online now 👉 https://lnkd.in/ekEK97x5
How Can Doctors in Good Conscience Continue Recommending 42 Radiation Sessions for Prostate Cancer When 5 Are as Safe and Effective? The latest research published in the New England Journal of Medicine proves that 5 SBRT Radiation Therapy Sessions With CyberKnife Are As Effective and Safe as Other Types of Radiation Requiring 32 or 42 Treatment Sessions for Low-to-Intermediate-Risk Localized Prostate Cancer Five-fraction SBRT was non-inferior to control radiotherapy with respect to biochemical or clinical failure and may be an efficacious treatment option for patients with low-to-intermediate-risk localized prostate cancer. Go to CyberKnife Miami's blog now to see the research proving it. CyberKnife Center of Miami "The Beam of Life" #cancertreatmentmiami #cancertreatmentmiamifl #cyberknifeforprostatecancer #cyberknifetreatmentforprostatecancer https://lnkd.in/gcvs8fB8
Study demonstrated the efficacy and safety of relugolix with radiotherapy for men with localized and advanced prostate cancer from two randomized trials. https://ja.ma/3yl7Myh
📄🩻 Our article : A randomised trial of short‐ vs long‐term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06‐24 has been published in BJU International 💊 The URONCOR 06-24 trial is a prospective, multicentre, randomised, open- label, phase III, clinical trial. The aim of the trial is to determine the impact of short-term (6 months) vs long-term (24 months) ADT in combination with SRT on distant metastasis-free survival (MFS) in patients with prostate cancer with BCR after RP (intermediate and high risk). ▶️ This is the link : https://lnkd.in/g4v8KJZf
In a recent study, PSMA-PET/CT was able to detect metastases in 46% of patients who were classified with high-risk non-metastatic HSPC on conventional imaging, suggesting that conventional scans may routinely understage patients with prostate cancer. https://lnkd.in/e7CwHjUz
#Proton Therapy is not better than #IMRT in Prostate Cancer. - For many years, there has been debate regarding the potential superiority of proton therapy. Despite dosimetric equivalence in the high dose region, prostate patients have been attracted to proton facilities with promises of reduced toxicity. In this study presented at #ASTRO24, a multicenter phase III prospective randomized trial now proves that IMRT is equal to protons for cancer control and toxicity: https://lnkd.in/ecuuKfWz
Head & Neck Cancer: The latest research has been reviewed to identify which patients with head & neck squamous cell carcinoma can benefit the most from proton therapy. Check out the review in our latest research blog on the Blog Spot: https://bit.ly/3Jv6Auv #HeadandNeckCancer #HeadAndNeckCancer #HeadAndNeck #ENT #radonc #otolaryngology #HNSCC #FloridaProtonResearch #ProtonTherapy #BeatCancer
DIRIGENTE MEDICO presso ASP 208 SIRACUSA
7moWell done Andrei